Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
Sales | 10,097,600 | 10,921,660 | 10,581,970 | 9,190,480 | 9,834,464 |
Cost of Goods | 3,097,620 | 2,898,410 | 2,522,600 | 2,470,810 | 2,565,819 |
Gross Profit | 8,611,848 | 8,209,320 | 8,097,680 | 6,974,250 | 7,317,510 |
Operating Expenses | 5,943,160 | 5,149,810 | 5,152,050 | 4,747,530 | 5,624,159 |
Operating Income | 1,057,439 | 2,873,851 | 2,907,920 | 1,972,950 | 1,645,305 |
Interest Expense | 126,930 | 105,760 | 117,140 | 102,020 | 113,780 |
Other Income | 1,335,391 | -358,461 | -1,175,330 | 297,730 | -2,450,916 |
Pre-tax Income | 2,265,900 | 2,409,630 | 1,615,450 | 2,168,660 | -919,391 |
Income Tax | 364,270 | 617,410 | 355,500 | 565,050 | -890,750 |
Net Income Continuous | 1,658,470 | 3,289,781 | 3,226,661 | 2,816,590 | 240,058 |
Net Income | $1,658,470 | $3,289,781 | $3,226,661 | $2,816,590 | $240,058 |
EPS Basic Total Ops | 0.63 | 1.26 | 1.24 | 1.08 | 0.10 |
EPS Basic Continuous Ops | 0.63 | 1.26 | 1.24 | 1.08 | 0.10 |
EPS Diluted Total Ops | 0.63 | 1.26 | 1.24 | 1.08 | 0.10 |
EPS Diluted Continuous Ops | 0.63 | 1.26 | 1.24 | 1.08 | 0.10 |
EBITDA(a) | $1,057,439 | $2,873,851 | $2,907,920 | $1,972,950 | $1,645,305 |